Evaluating a new stentgraft for aortic arch conditions

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the outcomes of a triple inner branched aortic arch stentgraft in patients with aortic arch pathologies. It involves a multicenter registry approach, collecting data from various sites to evaluate the effectiveness and safety of the stentgraft. Patients aged 18 and older who have specific aortic arch conditions and are scheduled for treatment with this stentgraft will be included in the study. The study will follow patients over time to monitor their progress and outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 18 years or older
* Presence of Aortic arch pathology
* Treatment planned with triple inner branch from Terumo Aortic
* Availability of the patients during the follow up period
* Informing patients about the study and providing written informed consent

Exclusion Criteria:

* Women of childbearing age
* Patients under 18 years

Where it's running

• Muenster University Hospital
  Münster, Germany Recruiting

Study contacts

• Study coordinator: Alexander Oberhuber, MD, PhD
• Email: alexander.oberhuber@ukmuenster.de
• Phone: +49 251 8345781

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• GORE TBE Device in Zone 0/1 for Aortic Arch Conditions

  This study tests the GORE TAG Thoracic Branch Endoprosthesis in adults with aortic arch problems in Zone 0 or 1 to see how it performs over several years in routine care.

  Recruiting at 24 sites W.L.Gore & Associates · Scottsdale, Arizona and 23 other locations · NCT07166133

• Arcevo LSA stent graft for repairing aortic arch dissections and aneurysms

  This trial will test whether the Arcevo LSA stent graft can safely and effectively repair aortic arch and descending thoracic aortic dissections or aneurysms in adults.

  Recruiting at 26 sites Artivion Inc. · Birmingham, Alabama and 25 other locations · NCT07089576

• Triple-branched stent graft system for aortic arch lesions

  This trial tests whether the triple branched covered stent graft can safely treat aortic arch lesions and achieve a high 12‑month treatment success with a low 30‑day major adverse events in adults.

  Recruiting Changhai Hospital · Shanghai, Shanghai Municipality · NCT07067840

• Endovascular treatment for aortic arch diseases using a new stent-graft system

  This study is testing a new stent-graft system to see if it can safely and effectively treat aortic arch diseases like aneurysms and ulcers in patients aged 18 to 80.

  Recruiting at 16 sites Lifetech Scientific (Shenzhen) Co., Ltd. · Beijing and 16 other locations · NCT06520774

• A study on a new stent graft system for aortic arch aneurysms

  This study is testing a new stent graft system to see if it can safely and effectively treat aortic arch aneurysms in patients.

  Recruiting at 20 sites Hangzhou Endonom Medtech Co., Ltd. · Beijing and 19 other locations · NCT06385379

• Study of aortic arch anatomical variations

  This study looks at the different shapes of the aortic arch in people with and without aneurysms to see how a common variation might relate to heart problems.

  Recruiting IRCCS San Raffaele · Milan, Italy · NCT06235619

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.